INO ▼ -2.6% - Inovio Pharmaceuticals, Inc.
$INO FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis sm
30-OCT-2026 04:35 PM ET
Share this post
More filings for $INO
INO ▼ -0.6% - Inovio Pharmaceuticals, Inc.Nov 18, 2026INO ▲ +0.6% - Inovio Pharmaceuticals, Inc.Nov 18, 2026INO - Inovio Pharmaceuticals, Inc. - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 17, 2026INO - Inovio Pharmaceuticals, Inc. - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 17, 2026INO ▼ -1.4% - Inovio Pharmaceuticals, Inc.Nov 13, 2026INO ▼ -9.7% - Inovio Pharmaceuticals, Inc.Nov 11, 2026
View full $INO filing history →💬 Comments
Loading comments…
Leave a comment
